Evotec agrees to give US Merck access to facility of the future
Evotec acquires US biotech Just Biotherapeutics for $90 million
Pharma giants join £9.5 million dementia drug discovery collaboration
Galapagos expands fibrosis portfolio
Evotec and ABIVAX collaborate to develop novel antiviral agents
Evotec to acquire Aptuit, expanding leadership in external innovation
Eternygen GmbH closes €8.0 million series A financing led by Epidarex Capital
Evotec and ex scientia join forces to discover bispecific small molecule immuno-oncology therapeutics
Evotec and Pierre Fabre sign five-year compound management agreement
Evotec forms spin-off company
New UK facility to accelerate drug discovery
Evotec wins multi-year contract to manage National Cancer Institute Chemical Biology Consortium Screening Libraries
Sanofi, Evotec and Apeiron Biologics to develop novel immuno-oncology treatments
Sanofi and Evotec to develop new treatments for diabetes
Evotec and Sanofi sign definitive agreement for major multicomponent strategic alliance
